These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 2693012

  • 1. Computer simulation of plasma insulin and glucose dynamics after subcutaneous insulin injection.
    Berger M, Rodbard D.
    Diabetes Care; 1989; 12(10):725-36. PubMed ID: 2693012
    [Abstract] [Full Text] [Related]

  • 2. A pharmacodynamic approach to optimizing insulin therapy.
    Berger MP, Rodbard D.
    Comput Methods Programs Biomed; 1991 Apr; 34(4):241-53. PubMed ID: 1873991
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.
    Lepore M, Pampanelli S, Fanelli C, Porcellati F, Bartocci L, Di Vincenzo A, Cordoni C, Costa E, Brunetti P, Bolli GB.
    Diabetes; 2000 Dec; 49(12):2142-8. PubMed ID: 11118018
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Acute effects of intraperitoneal versus subcutaneous insulin delivery on glucose homeostasis in patients with NIDDM. Veterans Affairs Implantable Insulin Pump Study Group.
    Kelley DE, Henry RR, Edelman SV.
    Diabetes Care; 1996 Nov; 19(11):1237-42. PubMed ID: 8908387
    [Abstract] [Full Text] [Related]

  • 8. Improvement of basal hepatic glucose production and fasting hyperglycemia of type I diabetic patients treated with human recombinant ultralente insulin.
    Riccio A, Avogaro A, Valerio A, Zappella A, Tiengo A, Del Prato S.
    Diabetes Care; 1994 Jun; 17(6):535-40. PubMed ID: 8082521
    [Abstract] [Full Text] [Related]

  • 9. Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures.
    Roach P, Woodworth JR.
    Clin Pharmacokinet; 2002 Jun; 41(13):1043-57. PubMed ID: 12403642
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S, Torlone E, Ialli C, Del Sindaco P, Ciofetta M, Lepore M, Bartocci L, Brunetti P, Bolli GB.
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [Abstract] [Full Text] [Related]

  • 12. The action profile of lispro is not blunted by mixing in the syringe with NPH insulin.
    Joseph SE, Korzon-Burakowska A, Woodworth JR, Evans M, Hopkins D, Janes JM, Amiel SA.
    Diabetes Care; 1998 Dec; 21(12):2098-102. PubMed ID: 9839100
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Subcutaneous insulin substitution in insulin-dependent diabetes mellitus. Pharmacokinetic and pharmacodynamic studies.
    Olsson PO.
    Acta Med Scand Suppl; 1987 Dec; 718():1-78. PubMed ID: 3321929
    [Abstract] [Full Text] [Related]

  • 16. Glucose-insulin regulation model with subcutaneous insulin injection and evaluation using diabetic inpatients data.
    Wu Z, Chui CK, Hong GS, Khoo E, Chang S.
    Comput Methods Programs Biomed; 2013 Aug; 111(2):347-56. PubMed ID: 23756090
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Miscibility of human semisynthetic regular and lente insulin and human biosynthetic regular and NPH insulin.
    Olsson PO, Hans A, Henning VS.
    Diabetes Care; 1987 Aug; 10(4):473-7. PubMed ID: 3304898
    [Abstract] [Full Text] [Related]

  • 19. Models of subcutaneous insulin kinetics. A critical review.
    Nucci G, Cobelli C.
    Comput Methods Programs Biomed; 2000 Jul; 62(3):249-57. PubMed ID: 10837910
    [Abstract] [Full Text] [Related]

  • 20. Effects of meal carbohydrate content on insulin requirements in type 1 diabetic patients treated intensively with the basal-bolus (ultralente-regular) insulin regimen.
    Rabasa-Lhoret R, Garon J, Langelier H, Poisson D, Chiasson JL.
    Diabetes Care; 1999 May; 22(5):667-73. PubMed ID: 10332663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.